Rossella Bertulli
Fondazione IRCCS Istituto Nazionale dei Tumori(IT)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Vascular Tumors and Angiosarcomas, Gastrointestinal Tumor Research and Treatment, COVID-19 and healthcare impacts, Tuberous Sclerosis Complex Research
Most-Cited Works
- → Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial(2004)1,662 cited
- → Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution(2004)405 cited
- → Rhabdomyosarcoma in adults(2003)398 cited
- → Quality of Surgery and Outcome in Extra-Abdominal Aggressive Fibromatosis: A Series of Patients Surgically Treated at a Single Institution(2003)354 cited
- → Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial(2014)332 cited
- → A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient(2004)325 cited
- → Status of Surgical Margins and Prognosis in Adult Soft Tissue Sarcomas of the Extremities: A Series of Patients Treated at a Single Institution(2004)284 cited
- → Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A European Organisation for Research and Treatment of Cancer–Italian Sarcoma Group–Australasian Gastrointestinal Trials Group Study(2005)279 cited
- → Imatinib mesylate in chordoma(2004)268 cited
- → Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis(2001)252 cited